Treatment with non‐selective beta‐blockers affects the systemic inflammatory response to bacterial DNA in patients with cirrhosis

BACKGROUND & AIMS: The use of non‐selective beta‐blockers has been associated with lower rates of infection and reduced infection‐associated morbidity in patients with cirrhosis. However, it is unknown if these drugs modify the systemic inflammatory response to circulating bacterial DNA. METHODS...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Liver Int
Autors principals: Gimenez, Paula, Garcia‐Martinez, Irma, Francés, Rubén, Gonzalez‐Navajas, Jose M., Mauri, Montserrat, Alfayate, Rocío, Almenara, Susana, Miralles, Cayetano, Palazon, Jose M., Carnicer, Fernando, Pascual, Sonia, Such, José, Horga, José F., Zapater, Pedro
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Cirrhosis and Liver Failure
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6282820/
https://ncbi.nlm.nih.gov/pubmed/29802788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.13890
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars